Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurodevelopmental Therapy-Bobath Approach in The Early Term of Stroke; Safe and Effective

NCT03602326 is registered in ClinicalTrials.gov with Gokhan Yazici as lead sponsor.

NCT NCT03602326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03602326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurodevelopmental Therapy-Bobath Approach in The Early Term of Stroke; Safe and Effective
Lead sponsor
Gokhan Yazici
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2018
Completion date
July 13, 2018
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, stroke, acute